Nº 13. Marzo - Plan Nacional sobre drogas

NOVEDADES BIBLIOGRÁFICASSUMARIOS DE REVISTASLEGISLACIÓNNOVEDADES BIBLIOGRÁFICAS PRESENTACIÓN• READ J.P., BOLLINGER A.R., SHARKANSKY E. (2002) ASSESSMENT OF COMORBIDSUBSTANCE USE DISORDER AND POSTTRAUMATIC STRESS DISORDER. EN: OUI-METTE P.; ED. LIT., BROWN P.J.; ED. LIT. TRAUMA AND SUBSTANCE ABUSE: CAU-SES CONSEQUENCES AND TREATMENT OF COMORBID DISORDERS.- WASHING-TON D.C.: AMERICAN PSYCHOLOGICAL ASSOCIATION. P. 111-125|.R-4916• RIDENOUR T.A., FAZZONE P., COTTLER L.B. (2002) CLASSIFICATION AND ASSESS-MENT. EN: ESSAU C.A.; ED. LIT. SUBSTANCE ABUSE AND DEPENDENCE IN ADO-LESCENCE: EPIDEMIOLOGY RISK FACTORS AND TREATMENT.- PHILADELPHIA:BRUNNER-ROUTLEDGE. P. 21-62.R-4816Farmacología• ALDA M. (2002) GENETIC FACTORS AND LONG-TERM PROPHYLAXIS IN BIPOLARDISORDER. EN: LERER B.; ed. lit. PHARMACOGENETICS OF PSYCHOTROPICDRUGS.- CAMBRIDGE: CAMBRIDGE UNIVERSITY; p. 320-332.R-4829• BAN T.A. (2002) NEUROPSYCHOPHARMACOLOGY: THE INTERFACE BETWEENGENES AND PSYCHIATRIC NOSOLOGY. EN: LERER B.; ed. lit. PHARMACOGENE-TICS OF PSYCHOTROPIC DRUGS.- CAMBRIDGE: CAMBRIDGE UNIVERSITY, p. 36-56.R-4829• BAUMANN P., EAP C.B. (2002) PHARMACOGENETICS OF CHIRAL PSYCHOTROPICDRUGS. EN: LERER B.; ed. lit. PHARMACOGENETICS OF PSYCHOTROPIC DRUGS.-CAMBRIDGE: CAMBRIDGE UNIVERSITY, p. 181-214.R-4829• GELERNTER J., KRANZLER H. (2002) GENETIC VARIATION AND DRUG DEPENDEN-CE RISK FACTORS. EN: LERER B.; ed. lit. PHARMACOGENETICS OF PSYCHOTRO-PIC DRUGS.- CAMBRIDGE: CAMBRIDGE UNIVERSITY, p. 372-387.R-4829• LESCH K.P., BENNINGHOFF J., SCHMITT A. (2002) PSYCHOPHARMACOGENETIC-NEURODELOPMENTAL INTERFACE IN SEROTONERGIC GENE PATHWAYS. EN:LERER B.; ed. lit. PHARMACOGENETICS OF PSYCHOTROPIC DRUGS.- CAMBRID-GE: CAMBRIDGE UNIVERSITY, p. 95-126.R-4829• LERER B. (2002) GENES AND PSYCHOPHARMACOLOGY: EXPLORING THE INTER-FACE. EN: LERER B.; ed. lit. PHARMACOGENETICS OF PSYCHOTROPIC DRUGS.-CAMBRIDGE: CAMBRIDGE UNIVERSITY, p. 3-17.R-48296